| Old Articles: <Older 29591-29600 Newer> |
|---|
 |
The Motley Fool
April 11, 2008
Rich Smith |
Glassmaker Gone Gangbusters Commercial construction continues to boom, and stocks like Apogee along with it.   |
The Motley Fool
April 11, 2008
Brian Orelli |
St. Jude's Heartfelt Acquisition Medical-device maker St. Jude purchases tiny EP MedSystems. |
The Motley Fool
April 11, 2008
Tim Beyers |
And the 2008 Stock Madness Winner Is ... A tussle between two titans proves to be no match at all. The winner of the Stock Madness trophy for 2008 goes to Apple. |
The Motley Fool
April 11, 2008
Rick Aristotle Munarriz |
Diary of a Stock Market Loser Follow along weekly with a Motley Fool analyst as he tries to improve his investing success. |
The Motley Fool
April 11, 2008
Selena Maranjian |
Millionaires: An Endangered Species? Will you find yourself out of luck in your quest to become a millionaire? Or do you still have time to invest like one and become one? |
The Motley Fool
April 11, 2008
Rich Smith |
Third Time's the Charm for Boeing Bad news at Boeing is good news for its shareholders. |
The Motley Fool
April 11, 2008
Toby Shute |
A Power Player Takes Its Lumps Engineering and construction company Shaw Group had a terrific second fiscal quarter in pretty much every respect, yet the stock got rocked. |
The Motley Fool
April 10, 2008
Brian Lawler |
Nektar Can't Squeeze Nectar From This Drug Nektar Therapeutics announced that it was putting its inhaled insulin drug, Exubera, to rest. Investors, take note. |
The Motley Fool
April 10, 2008
Alyce Lomax |
Retail Comps Cower in March Consumer-centric companies stumbled last month as shoppers pinched pennies. |
The Motley Fool
April 10, 2008
Brian Lawler |
Glaxo Angers the FDA GlaxoSmithKline announces that the FDA has sent it a warning letter regarding its failure to meet certain post-marketing requirements for Avandia. |
| <Older 29591-29600 Newer> Return to current articles. |
